Q4 Earnings Highlights: Hillenbrand (NYSE:HI) Vs The Rest Of The General Industrial Machinery Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how general industrial machinery stocks fared in Q4, starting
3 Reasons MANH is Risky and 1 Stock to Buy Instead
Manhattan Associates’s stock price has taken a beating over the past six months, shedding 39.3% of its value and falling to $164.02 per share. This was partly driven by its softer quarterly results
3 Reasons to Avoid GPRO and 1 Stock to Buy Instead
GoPro’s stock price has taken a beating over the past six months, shedding 48.3% of its value and falling to $0.69 per share. This might have investors contemplating their next move.
Real Estate Services Stocks Q4 In Review: Compass (NYSE:COMP) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Compass (NYSE:COMP) and its peers.
Q4 Rundown: RTX (NYSE:RTX) Vs Other Defense Contractors Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how RTX (NYSE:RTX) and the rest
Spotting Winners: NN (NASDAQ:NNBR) And Engineered Components and Systems Stocks In Q4
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at NN (NASDAQ:NNBR) and the best and worst p
3 Reasons to Sell PBI and 1 Stock to Buy Instead
While the broader market has struggled with the S&P 500 down 1.3% since September 2024, Pitney Bowes has surged ahead as its stock price has climbed by 39.6% to $9.27 per share. This was partly due to
Winners And Losers Of Q4: Bel Fuse (NASDAQ:BELFA) Vs The Rest Of The Electronic Components Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Bel Fuse (NASDAQ:BELFA) and
3 Reasons IART is Risky and 1 Stock to Buy Instead
While the broader market has struggled with the S&P 500 down 1.3% since September 2024, Integra LifeSciences has surged ahead as its stock price has climbed by 31.6% to $22.79 per share. This performa
3 Reasons to Avoid TASK and 1 Stock to Buy Instead
TaskUs currently trades at $13.28 per share and has shown little upside over the past six months, posting a middling return of 3.6%.